Actinium Pharmaceuticals, Inc. (ATNM)
EBITDA Margin
34.71%
TTM · Period ending:
ATNM EBITDA Margin
Latest reported34.71%period ending
Latest reported34.71%period ending
ATNM TTM EBITDA Margin (312212.05% → 34.71%)
TTM ebitda margin
High-resolution chart · PNG
ATNM ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 34.7136% | |
| -25,150% | |
| -36,740% | |
| -37,533.3333% | |
| -49,517.284% | |
| -51,628.3951% | |
| -56,329.6296% | |
| -59,293.8272% | |
| -101,257.7778% | |
| -42,423.3333% | |
| -3,137.6699% | |
| -2,820.9877% | |
| -2,154.8751% | |
| -1,644.8016% | |
| -2,124.3007% | |
| -2,028.9028% | |
| -2,472.5225% | |
| -3,475.5627% | |
| 928,709.072% | |
| 822,001.662% | |
| 815,630.8172% | |
| 312,212.0499% |